Gestational trophoblastic disease: a profile of 37 cases
Keywords:
GTD, Choriocarcinoma, Invasive mole, ChemotherapyAbstract
Background: Objective of current study was to study the demographic details, pattern of presentation and response to the treatment in the patients presenting with Gestational Trophoblastic Disease (GTD).
Methods: The present study was conducted in a tertiary teaching institute as a retrospective plus prospective study over a period of 5 years from August 2004 to August 2009. Total 37 cases were studied out of which 16 were studied retrospectively from the case record and 21 were studied prospectively. Patients were evaluated on the basis of their age, number of deliveries, history of abortion or molar pregnancy and the treatment received.
Results: 37 cases of gestational trophoblastic disease were studied in a period of 5 years from August 2004 to August 2009. The incidence of gestational trophoblastic disease was 1in 600 deliveries with the mean age of patients being 26.9 years. Most common chief complaint at presentation was bleeding per vaginum after a period of amenorrhoea seen in 31 patients (84%) followed by hyperemesis seen in 8 (19%) patients. Out of 37 patients 29 (78%) had complete mole & 8 (22%) had partial mole, the ratio of being 3.6:1. Complete cure rate in present study was seen in 31 out of 37 (84%) patients and mortality was seen in 2.7%.
Conclusions: Gestational trophoblastic disease is seen most commonly in reproductive age group. This is a highly curable tumor even in the presence of distant metastasis.
References
Berkowitz RS, Goldstein DP. Gestational trophoblastic neoplasia. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology. 2nd ed. Baltimore, MD: Williams & Wilkins; 1994: 441-468.
Grimes DA. Choriocarcinoma: epidemiology. J Reprod Med. 2002;39(3):155-62.
ACOG Practice Bulletin 53. Diagnosis and treatment of gestational trophoblastic neoplasms. Obstet Gynecol. 2004;103:1365-77.
Daftary SN, Padubidri VG Trophoblastic diseases In: Padubidri VG, Daftary SN, eds. Shaw’s Text Book of Gynaecology. 13th ed. Chicago: J. & A. Churchill Limited; 2004 248-259.
Shakuntala Chhabra & Ambreen Qureshi, Gestational trophoblastic neoplasms with special reference to invasive mole. J Obstet Gynecol India. 2007;57(2):124-7.
Moodley M, Tunkyi K, Moodley J Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):234-9.
American Cancer Society. How is gestational trophoblastic disease diagnosed? 2012. Available at: http://www.cancer.org/docroot/CRI. Accessed 26 September 2012.
Chattopadhyay SK, Sengupta BS, AL Ghreimil M, Edrees WB, Lmbourne A. Epidemiologic study of gestational trophoblasic diseases in Saudi Arabia. Surg Gynecol Obstet. 1988;167(5):393-8.
Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C. EMA/CO regimen in hich-risk gestational trophoblastic tumor (GTT). Gynecol Oncol. 1988;31:439-44.